These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 37822929)

  • 1. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.
    Mukherjee S; Patra R; Behzadi P; Masotti A; Paolini A; Sarshar M
    Front Immunol; 2023; 14():1244345. PubMed ID: 37822929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-Like Receptors in Adaptive Immunity.
    Kumar V
    Handb Exp Pharmacol; 2022; 276():95-131. PubMed ID: 34510306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications.
    Chen YH; Wu KH; Wu HP
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity.
    Kawai T; Ikegawa M; Ori D; Akira S
    Immunity; 2024 Apr; 57(4):649-673. PubMed ID: 38599164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors in health and disease.
    Wang K; Huang H; Zhan Q; Ding H; Li Y
    MedComm (2020); 2024 May; 5(5):e549. PubMed ID: 38685971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.
    Hanke ML; Kielian T
    Clin Sci (Lond); 2011 Nov; 121(9):367-87. PubMed ID: 21745188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress of research on TLRs-mediated signaling pathway].
    Chang XT; Nian XF; Wang ZH
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):340-6. PubMed ID: 22242400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
    Sun L; Liu W; Zhang LJ
    J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of immune responses to infection through interaction between stem cell-derived exosomes and toll-like receptors mediated by microRNA cargoes.
    Moghaddam MM; Behzadi E; Sedighian H; Goleij Z; Kachuei R; Heiat M; Fooladi AAI
    Front Cell Infect Microbiol; 2024; 14():1384420. PubMed ID: 38756232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists.
    Keshavarz A; Pourbagheri-Sigaroodi A; Zafari P; Bagheri N; Ghaffari SH; Bashash D
    IUBMB Life; 2021 Jan; 73(1):10-25. PubMed ID: 33217774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.
    Ofodile ON
    J Ind Microbiol Biotechnol; 2007 Dec; 34(12):751-62. PubMed ID: 17876621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.
    Yang Y; Feng R; Wang YZ; Sun HW; Zou QM; Li HB
    Immunol Lett; 2020 Jul; 223():1-9. PubMed ID: 32311408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Effects of Toll-Like Receptor Signaling on the Activation of Immune Responses in the Upper Respiratory Tract.
    Xu M; Li N; Fan X; Zhou Y; Bi S; Shen A; Wang B
    Microbiol Spectr; 2022 Feb; 10(1):e0114421. PubMed ID: 35196817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells.
    Kumar MV; Nagineni CN; Chin MS; Hooks JJ; Detrick B
    J Neuroimmunol; 2004 Aug; 153(1-2):7-15. PubMed ID: 15265658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-Like Receptors: General Molecular and Structural Biology.
    Behzadi P; García-Perdomo HA; Karpiński TM
    J Immunol Res; 2021; 2021():9914854. PubMed ID: 34195298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
    Tartey S; Takeuchi O
    Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.
    Wicherska-Pawłowska K; Wróbel T; Rybka J
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention.
    Zou H; Wang WK; Liu YL; Braddock M; Zheng MH; Huang DS
    Expert Opin Ther Targets; 2016 Sep; 20(9):1127-35. PubMed ID: 26998881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.